Clinical Trial Update: Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 2 study investigating the biology of IDH-mutant gliomas by longitudinally tracking 2-hydroxyglutarate (2-HG) usi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• High-grade Glioma
• Low-grade Glioma
• Malignant Glioma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Glioma, Gliomas | Phase 2 | Status: SUSPENDED